7.5 mg, film-coated tablets
(Zofenopril calcium)
Table of contents of the leaflet:
Zofenil 7.5 contains 7.5 mg of zofenopril calcium, which belongs to a group of blood pressure-lowering medicines called angiotensin-converting enzyme inhibitors (ACE inhibitors).
Zofenil 7.5 is used to treat the following conditions:
Before starting treatment with Zofenil 7.5, discuss it with your doctor.
Tell your doctor:
Your doctor may recommend regular monitoring of kidney function, blood pressure, and electrolyte levels (e.g., potassium) in the blood.
See also the section "When not to take Zofenil 7.5".
Zofenil 7.5 may cause excessive, sudden lowering of blood pressure, especially after the first dose (this risk increases when taking diuretics, in case of dehydration, or when following a low-salt diet). If this happens, lie down and immediatelycontact your doctor.
In case of surgery, before receiving anesthesia, inform the anesthesiologistthat you are taking Zofenil 7.5. This will allow for proper control of blood pressure and heart rate during the procedure.
Additionally, in patients with heart attack(acute myocardial infarction) and:
Tell your doctor if you suspect or plan to become pregnant. Zofenil 7.5 is not recommended during early pregnancy and should not be taken after the third month of pregnancy, as it may seriously harm the baby (see "Pregnancy and breastfeeding").
Do not give this medicine to children and adolescents under 18 years of age, as the safety of the medicine has not been established.
Tell your doctor about all medicines you are currently taking or have recently taken, as well as any medicines you plan to take.
In particular, tell your doctor if you are taking:
Zofenil 7.5 can be taken with or without food, preferably with a glass of water.
Alcohol enhances the blood pressure-lowering effect of Zofenil 7.5. For more information on consuming alcohol while taking this medicine, consult your doctor.
Pregnancy
If you are pregnant, think you may be pregnant, or plan to have a baby, consult your doctor before taking this medicine. Your doctor will usually recommend stopping Zofenil 7.5 before planned pregnancy or as soon as pregnancy is confirmed, and recommend taking a different medicine instead of Zofenil 7.5.
Zofenil 7.5 is not recommended during early pregnancy and should not be taken after the third month of pregnancy, as it may seriously harm the baby.
Breastfeeding
If you are breastfeeding or plan to breastfeed, consult your doctor before taking this medicine. Zofenil 7.5 is not recommended for breastfeeding mothers. Your doctor may recommend a different medicine while breastfeeding, especially if you are breastfeeding a newborn or premature baby.
The medicine may cause dizziness and fatigue. If you experience these symptoms, do not drive or operate machinery.
The medicine contains lactose. If you have been diagnosed with intolerance to some sugars, consult your doctor before taking the medicine.
This medicine contains less than 1 mmol (23 mg) of sodium per film-coated tablet, which means it is considered "sodium-free".
Always take this medicine exactly as your doctor has told you. If you are unsure, consult your doctor.
Zofenil 7.5 can be taken with or without food, preferably with a glass of water.
Treatment of high blood pressure(hypertension)
The usual initial dose of Zofenil 7.5 is 15 mg, once daily. Your doctor will gradually adjust the dose (usually at 4-week intervals) to determine the optimal dose for you. The long-term antihypertensive effect is usually achieved with a dose of 30 mg of Zofenil 7.5, once daily. The maximum dose is 60 mg per day, given in a single dose or two divided doses.
In case of dehydration, low salt levels, or diuretic use, it may be necessary to start treatment with a dose of 7.5 mg of Zofenil 7.5.
Liver or kidney disease
In case of mild to moderate liver function disorders or moderate to severe kidney function disorders, your doctor will start treatment with half the usual recommended dose (15 mg). If you are undergoing dialysis, treatment will start with one-quarter of the usual recommended dose (7.5 mg).
Treatment of heart attack(acute myocardial infarction)
Your doctor will start Zofenil 7.5 within the first 24 hours of symptom onset.
The medicine is given twice daily, in the morning and evening, as follows:
If you have accidentally taken too many tablets, contact your doctor or go to the emergency department of the nearest hospital (taking any remaining tablets, packaging, or leaflet - if possible).
The most common symptoms of overdose are excessively low blood pressure with fainting (hypotension), very slow heart rate (bradycardia), blood biochemical changes (electrolyte disturbances), and kidney function disorders.
If you miss a dose, take the next dose as soon as you remember.
However, if the delay is long (e.g., several hours) and the next dose is soon due, wait and take the next scheduled dose at the usual time. Do not take a double dose to make up for the missed dose.
Before stopping the medicine, consult your doctor, whether you are taking Zofenil 7.5 for high blood pressure or after a heart attack.
If you have any further doubts about taking this medicine, consult your doctor or pharmacist.
Like all medicines, Zofenil 7.5 can cause side effects, although not everybody gets them.
Side effects associated with ACE inhibitors are usually temporary and disappear after treatment is stopped.
Common side effects(may occur in less than 1 in 10 patients):
Uncommon side effects(may occur in less than 1 in 100 patients):
Rare side effects(may occur in less than 1 in 1,000 patients):
In addition to the side effects of Zofenil 7.5, the following side effects are typical of ACE inhibitors:
If you experience any side effects, including those not listed in this leaflet, tell your doctor or pharmacist or nurse.
Side effects can be reported directly to the Department of Adverse Reaction Monitoring of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C, 02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep out of the sight and reach of children.
No special storage conditions are required.
Do not use this medicine after the expiry date stated on the packaging and blister after the "EXP" abbreviation. The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
The active substance of the medicine is zofenopril calcium 7.5 mg.
The other ingredients are: microcrystalline cellulose, lactose monohydrate, sodium croscarmellose, magnesium stearate, anhydrous colloidal silica. Coating: hypromellose, titanium dioxide (E171), macrogol 400, and macrogol 6000 (see section 2 "Zofenil 7.5 contains lactose").
Zofenil 7.5 is a white, round, flat, film-coated tablet, available in packs of 7, 14, and 28 film-coated tablets.
Not all pack sizes may be marketed.
Marketing authorization holder
BERLIN-CHEMIE AG
Glienicker Weg 125
12489 Berlin, Germany
Manufacturer
Menarini - Von Heyden GmbH
Leipziger Strasse 7-13
For more information, contact the representative of the marketing authorization holder:
Berlin-Chemie/Menarini Polska Sp. z o.o.
Phone: (22) 566 21 00
Fax: (22) 566 21 01
Date of last revision of the leaflet:12/2024
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.